PFE vs TTD: Which Is the Better Buy?

Side-by-side comparison of Pfizer Inc. and The Trade Desk, Inc. โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-05-09.
Pfizer Inc. ยท Healthcare
$26.33
+28.6% upside to fair value
Grade B
VS
The Trade Desk, Inc. ยท Technology
$23.08
+45.0% upside to fair value
Grade B High Quality
QuantHub Verdict
TTD has more upside to fair value (+45.0%). PFE trades at a lower forward P/E (19.3x). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric PFE TTD
Current Price $26.33 $23.08
Fair Value Estimate $33.85 $33.47
Upside to Fair Value +28.6% +45.0%
Market Cap $149.8B $10.8B
Forward P/E 19.3x 25.3x
EV / EBITDA 12.9x 14.3x
Price / Sales 2.4x 3.6x
Price / FCF 16.5x 13.0x
Revenue Growth YoY -1.2% +11.8%
Gross Margin 70.3% 77.8%
Operating Margin 24.7% 20.3%
Return on Equity 8.7% 16.9%
Dividend Yield 0% 0%
FCF Yield 6.06% 7.71%
Analyst Consensus Hold Hold
Investment Thesis
PFE โ€” Pfizer Inc.
Pfizer Inc. is a leading global pharmaceutical company specializing in drug manufacturing with a strong presence in vaccines, oncology, and primary care. The company benefits from a seasoned leadership team under CEO Albert Bourla, who has driven a strategic transformation focusing on science-driven innovation and portfolio optimization. Despite a high gross margin of 70.3% and solid operating maโ€ฆ
TTD โ€” The Trade Desk, Inc.
The Trade Desk, Inc. operates a leading self-service, cloud-based programmatic advertising platform focused on demand-side platform services, primarily in connected TV and audio advertising. The company benefits from a durable competitive moat driven by network effects, high customer retention above 95%, and a founder-led management team with deep industry expertise. Despite solid revenue growth โ€ฆ
Accumulation Zones
Metric PFE TTD
Zone Low $25.39 $25.10
Zone High $28.77 $28.45
In Buy Zone? Yes Yes
โ† PFE Research    TTD Research โ†’    All Research